Results 241 to 250 of about 43,453 (280)

Synergistic Anti-Cancer Effects of Isocnicin and Radiotherapy in Glioblastoma: A Natural Compound's Potential. [PDF]

Biomedicines
Tsafa E, Dimitriadis K, Kalampoki L, Papapetrou P, Georgalis PA, Bozios G, Sioka C, Tsekeris P, Kyritsis AP, Alexiou GA, Lazari D.   +10 more
europepmc   +1 more source

Synergistic activity of fosfomycin and flucloxacillin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus: in vitro and in vivo assessment. [PDF]

Med Microbiol Immunol
Nussbaumer-Pröll A, Obermüller M, Weiss-Tessbach M, Eberl S, Zeitlinger M, Matiba B, Mayer C, Kussmann M.   +7 more
europepmc   +1 more source

In Vitro Susceptibility to Imipenem/Relebactam and Comparators in a Multicentre Collection of <i>Mycobacterium abscessus</i> Complex Isolates. [PDF]

Antibiotics (Basel)
Seoane-Estévez A, Aja-Macaya P, Garcia-Pose A, López-Roa P, Ruedas-López A, Gonzalez-Galán V, Esteban J, Arca-Suárez J, Pampín M, Beceiro A, Oviaño M, Bou G, On Behalf Of The Geim-Seimc Study Group.   +12 more
europepmc   +1 more source

One-Health Approach to Managing Aflatoxin-Producing Aspergillus flavus Using Spent Mushroom Substrate of <i>Pleurotus</i> spp. [PDF]

ACS Omega
de Araújo WM, Silva EP, da Silva GCS, Silva LSF, de Medeiros FD, Gonçalves JE, Dantas BB, Silva KKF, Silva ALE, Tavares JF, Zárate-Salazar JR, Moura-Mendes J, Pereira FO.   +12 more
europepmc   +1 more source

Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathway. [PDF]

Sci Rep
Banchi M, Cox MC, Orlandi P, Bandini A, Stefanelli F, Chericoni S, Bocci G.   +6 more
europepmc   +1 more source

Sensitization of melanoma cells to standard chemotherapy: G-quadruplex binders as synergistic agents. [PDF]

NAR Cancer
Persico C, Iaccarino N, Romano F, Giustiniano M, Russo C, Laneri S, Di Lorenzo R, Aiello I, Abate S, Izzo L, Merlino F, Brancaccio D, Pagano B, Amato J, Marzano S, D'Aria F, De Tito S, Di Porzio A, Randazzo A.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug synergism as a basis for rational neuroprotection

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2022
Optimization of the choice of neuroprotective therapy regimens in patients with CVD, taking into account the synergism of drug interactions, is basic in real clinical practice. Unfortunately, in modern pharmacology there is no unified way to establish the synergistic spectrum of action of drugs, which would allow systematic investigation of the effects
M.V. Putilina, N.V. Teplova
openaire   +2 more sources

Teratogenic Risks of Drug Synergism

Nature, 1964
IT is well known that the effectiveness of teratogens, measured either in incidence or in severity of resulting malformations, is frequently modified, in a plus or minus direction, by unrelated external conditions. The mechanisms by which these modifying agencies operate are largely unknown.
Ellen M. Clark, Walter Landauer
openaire   +3 more sources

Communicating Synergism in Drug Combination Studies

Arzneimittelforschung, 2011
Isobolograms are used to identify synergistic effects of drugs given in combination. However, the traditional isobologram provides only a qualitative determination of synergism. The present report describes two procedures for quantifying the synergistic actions of drugs based on isobolographic plots.
Harlan E. Shannon, Jesse Brodkin
openaire   +3 more sources

A Fatality Due to Drug Synergism

Medicine, Science and the Law, 1982
Thioridazine is a phenothiazine tranquillizer with specificity for psychotherapeutic action. It is well tolerated but will induce changes in myocardial repolarization which are further aggravated in the presence of low blood potassium levels. Fatalities due to overdosage of thioridazine are rare and those associated with therapeutic dosage and cross ...
openaire   +3 more sources